Cancer center advertising: claims and stories

People who read cancer center advertising are often frightened, short on time and willing to try almost anything. Regulators know that, which is why cancer claims have drawn some of the FTC’s and FDA’s sharpest warnings, and why Google names cancer in its own advertising policies. An oncology practice or cancer center that advertises carefully has an advantage: it can be the clear, honest voice in a space crowded with overpromises.

This guide covers the words that cause trouble, how to use patient stories and testimonials within the FTC rules, what Google allows for experimental treatments and clinical trials, and a marketing plan that stays inside those limits. It does not cover clinical decisions, which belong to your physicians. Survivorship programs that treat lymphedema should read lymphedema clinic marketing.

This is general information, not legal or medical advice. Sources cited were checked on October 29, 2026: the FTC press release FTC Sweep Stops Peddlers of Bogus Cancer Cures (September 18, 2008); the FDA consumer update Products Claiming to Cure Cancer Are a Cruel Deception (content current as of September 4, 2020); the FTC Health Products Compliance Guidance (December 2022); 16 CFR 255.2 and 255.5; 16 CFR Part 465; 45 CFR 164.508; and the Google Ads Unreliable claims, Healthcare and medicines, Speculative and experimental medical treatment and Personalized advertising policies. Have a health care attorney review your advertising.

Why cancer claims get extra scrutiny

In September 2008 the FTC announced 11 law enforcement actions against companies it charged with making unsupported claims that their products cured or treated one or more types of cancer. Some complaints also alleged that the companies falsely touted clinical or scientific proof. The investigation began with an internet search run jointly by the FTC, the FDA and Competition Bureau Canada, and the FDA sent its own warning letters saying that products claiming to cure, treat, mitigate or prevent cancer without being proven safe and effective were unapproved new drugs.

Those cases were about products, not cancer centers, but the principle applies to anyone advertising cancer care. The FTC Health Products Compliance Guidance says health claims need competent and reliable scientific evidence, and that an advertiser is responsible for the net impression of an ad, including implied claims. It also gives a cancer example that matters for any oncology advertiser: an ad implying a product treats cancer is likely to mislead even if it carries a clear disclaimer that there is no scientific support, because the strong effect of the claim on a potentially vulnerable consumer could overwhelm the disclaimer. A footnote does not fix a misleading headline.

Words to keep out of oncology ads

The FDA consumer update on fake cancer cures lists phrases it says consumers should treat as red flags. A legitimate cancer center should avoid them too, because they are exactly what a reader has been taught to distrust:

Treats all forms of cancer
Miraculously kills cancer cells and tumors
Shrinks malignant tumors
Selectively kills cancer cells
More effective than chemotherapy
Attacks cancer cells, leaving healthy cells intact
Cures cancer

Google’s Unreliable claims policy points the same way. It does not allow claims that entice the user with an improbable result as the likely outcome, even if that result is possible, and it lists unproven claims of cures for incurable medical ailments, with miracle cures for cancer as an example. Google also says it may defer to local regulatory guidelines for health-related claims, including testimonial content.

The same caution covers survival and outcome language. Phrases such as better survival rates, best outcomes in the region or beat cancer here are claims about results. Each would need substantiation for the specific comparison it makes, and cancer outcomes depend on far more than the center. Most centers are better served by leaving outcome language out of general advertising altogether.

What to say instead is usually what patients are looking for anyway: which cancers and services you treat, who is on the team, how quickly a new patient can be seen if you track that accurately, what support services you offer, which insurance you take, where you are and whether you take part in clinical trials. Every one of those can be stated plainly and checked. If you run an infusion suite, our guide to infusion center marketing covers manufacturer copay coupons and drug names in ads.

If your center offers palliative care alongside treatment, describe it as care that can continue with treatment and keep it apart from hospice on every page. Our guide to palliative care marketing covers that wording, coverage lines and family contact.

Patient stories and testimonials

Cancer patients often want to hear from someone who has been through the same thing, and many survivors want to share their experience. Stories can be done well, with four rules in mind:

A testimonial is your claim. The FTC Health Products Compliance Guidance says advertisers should not make claims through consumer testimonials that would be deceptive or could not be substantiated if the advertiser made them directly. It is not enough that the testimonial is the patient’s honest experience; the advertiser needs evidence for the implied claim that the treatment will work for others as it did for that patient.
One story reads as typical. Under 16 CFR 255.2(b), an ad that presents one patient’s experience on a key point is likely to be read as what patients generally experience. Unless you can substantiate that, the ad should clearly disclose what patients can generally expect. The guidance adds that when an ad targets a specific audience, a disclosure is judged from that audience’s perspective, and for people facing cancer that is a high bar.
Disclose connections. If a patient in an ad was paid, given free care or has another connection to the center that readers would not expect, 16 CFR 255.5 requires that connection to be clearly disclosed.
Get written authorization. If the center is a HIPAA covered entity, using a patient’s story, photo or name in marketing generally needs the patient’s written authorization under 45 CFR 164.508. See our guide to HIPAA marketing rules.

In practice, the safest and often most useful stories are about the experience of care rather than the result: how the first appointment was arranged, what the nurse navigator did, how the team explained the options, what support the family received. Illustration: a story in which a patient describes how the center coordinated scans, a surgical consult and a social worker in the same week tells readers something true about the center without implying any particular outcome. Our guide to patient testimonials and before-and-after photos covers the rules in more detail.

Reviews follow their own rule. 16 CFR Part 465 prohibits fake reviews and, in section 465.4, incentives conditioned on a review expressing a particular sentiment. Ask every patient for honest feedback, not only those with good news, and keep replies free of health details; see our guide to replying to patient reviews.

Experimental treatments and clinical trials

Google’s healthcare policy does not allow the promotion of speculative or experimental medical treatments, and it does not allow the promotion of cell or gene therapies except, in the United States, FDA licensed or approved cell or gene therapies promoted by the entities that hold that license or approval. Clinical trial recruitment ads are not allowed in most locations, and where they are allowed, they may not promote prescription drugs, create misleading expectations about the product being tested or imply that it is safe.

The FDA consumer update notes that there are legal ways for patients to access investigational drugs, for example taking part in clinical trials, and points patients to the National Cancer Institute clinical trials website. For a center, that suggests a simple approach: describe trial participation factually on your own website, link to the official trial listings, and do not advertise access to unproven treatments. Our guide to clinical trial recruitment ads covers the rules for recruitment.

Ad targeting and website privacy

Health is a sensitive interest category in Google’s personalized advertising policy, and Google says advertisers promoting products and services in sensitive interest categories cannot use advertiser-curated audiences, such as remarketing lists. Build oncology campaigns on search intent and location: people searching for a cancer center, a specific service or a second opinion in your area.

Website tracking needs the same care. A page view on a page about a specific cancer, or a form asking about a diagnosis, can reveal something sensitive about the visitor. Keep advertising tags off pages and forms that collect health information; our guide to tracking pixels on practice websites explains why.

A marketing plan that works inside the rules

Illustration: an independent oncology practice wants more new patient referrals and self-referred second opinions. A plan in this order covers the basics.

Audit existing claims. Read every ad, page and social post for the red flag phrases above and for survival or outcome language, and rewrite them as factual descriptions of services.
Build clear service pages. One page per cancer type or service you treat, explaining what a first visit involves, who the patient will meet and how to prepare, without drug brand names or outcome promises.
Make the first step easy. A direct new patient line, a simple form that does not ask for a diagnosis in free text, and a clear statement of how quickly you respond.
Serve referring physicians. A referral page with a direct number, what records to send and how quickly you send notes back. See our guide to patient and physician referrals.
Run search ads on clear intent. Target searches for cancer care, specific services and second opinions in your area, with landing pages that match the ad.
Tell care stories with authorization. Focus on the experience of care, get written authorization and disclose any connection.

How we handle this

When we build new patient programs for a practice, we write ads and landing pages around services, access and support, keep outcome promises and drug names out, and track inquiries without sending health information to ad platforms. We do not sell or buy lead lists. Our work is built with HIPAA in mind, and we confirm in writing what a BAA covers before any patient information flows through a tool; if it is not covered, we do not route patient information through it. See our medical lead generation service for how we approach it.

Can a cancer center advertise its survival rates?

Only with care and counsel’s review. A survival or outcome figure is a claim about results, which the FTC expects to be substantiated for the specific comparison it makes and judged by the net impression it leaves. Many centers leave outcome figures out of general advertising and describe services, team and access instead.

Does a disclaimer make a strong cancer claim acceptable?

Not reliably. The FTC Health Products Compliance Guidance gives a cancer example in which a clear disclaimer does not cure the misleading net impression, because the strong effect of the claim on a vulnerable consumer could overwhelm it.

Can we use a patient’s survivor story in an ad?

If you are a HIPAA covered entity, you need the patient’s written authorization. Under 16 CFR 255.2(b), one patient’s experience is likely to be read as typical unless you can substantiate that or disclose what patients generally experience, and any material connection must be disclosed under 16 CFR 255.5.

Can we run Google Ads for an experimental treatment?

Google’s healthcare policy does not allow the promotion of speculative or experimental medical treatments, and clinical trial recruitment ads are not allowed in most locations. Describe trial participation factually on your website instead. For the wider rules, see how to write healthcare practice ad copy without breaking advertising rules.

Which words should we avoid in oncology ads?

Start with the FDA’s red flag list, including cures cancer, treats all forms of cancer, shrinks malignant tumors and more effective than chemotherapy, and avoid survival or outcome promises in general advertising.

Can we use remarketing for cancer center ads?

Google’s personalized advertising policy treats health as a sensitive interest category and does not allow advertiser-curated audiences, such as remarketing lists, when promoting services in that category. Use search intent and location instead.

Cancer center and oncology advertising: claims, patient stories, trials and ads